MDMA decreases the effects of simulated social rejection - PubMed (original) (raw)
MDMA decreases the effects of simulated social rejection
Charles G Frye et al. Pharmacol Biochem Behav. 2014 Feb.
Abstract
3-4-Methylenedioxymethamphetamine (MDMA) increases self-reported positive social feelings and decreases the ability to detect social threat in faces, but its effects on experiences of social acceptance and rejection have not been determined. We examined how an acute dose of MDMA affects subjective and autonomic responses to simulated social acceptance and rejection. We predicted that MDMA would decrease subjective responses to rejection. On an exploratory basis, we also examined the effect of MDMA on respiratory sinus arrhythmia (RSA), a measure of parasympathetic cardiac control often thought to index social engagement and emotional regulation. Over three sessions, healthy adult volunteers with previous MDMA experience (N=36) received capsules containing placebo, 0.75 or 1.5 mg/kg of MDMA under counter-balanced double-blind conditions. During expected peak drug effect, participants played two rounds of a virtual social simulation task called "Cyberball" during which they experienced acceptance in one round and rejection in the other. During the task we also obtained electrocardiograms (ECGs), from which we calculated RSA. After each round, participants answered questionnaires about their mood and self-esteem. As predicted, MDMA decreased the effect of simulated social rejection on self-reported mood and self-esteem and decreased perceived intensity of rejection, measured as the percent of ball tosses participants reported receiving. Consistent with its sympathomimetic properties, MDMA decreased RSA as compared to placebo. Our finding that MDMA decreases perceptions of rejection in simulated social situations extends previous results indicating that MDMA reduces perception of social threat in faces. Together these findings suggest a cognitive mechanism by which MDMA might produce pro-social behavior and feelings and how the drug might function as an adjunct to psychotherapy. These phenomena merit further study in non-simulated social environments.
Keywords: Cyberball; MDMA; Respiratory sinus arrhythmia; Social cognition.
Copyright © 2013 Elsevier Inc. All rights reserved.
Figures
Figure 1
Replication of typical MDMA effects: MDMA dose-dependently increases subjective feelings of “high-ness” and “loving-ness” and increases heart rate. Solid traces indicate the high dose, dashed the low, and dotted the placebo. Symbols indicate significant differences from 0 (p<.05 using the Wilcoxon Signed-Rank test) for the medians of the following change scores: &, high – placebo; %, low – placebo; #, high – low. Error bars represent standard error of the mean. Arrows indicate the timing of capsule administration and Cyberball, the social simulation game. Top, responses to “are you high right now?”; Center, responses to “do you feel loving?”; Bottom, mean heart rates in beats per minute.
Figure 2
The high dose of MDMA increases self-reported mood, self-esteem, and reported percentage of throws received after rejection during a ball-tossing social simulation game without increasing them after acceptance in the same. Color indicates dose as follows: dark gray, high; light gray, low; white, placebo. Symbols indicate significant differences from 0 (p<.05 using Student’s _T_-test) for the following change scores: &, high – placebo; %, low – placebo; #, high – low. Error bars represent standard error of the mean. The thick black line in the right panel indicates the correct value for percentage throws received in each condition.
Figure 3
MDMA dose-dependently decreases respiratory sinus arrhythmia (RSA), and there was no detectable effect of Cyberball on RSA. Color indicates dose as follows: dark gray, high; light gray, low; white, placebo. Symbols indicate significant differences from 0 (p<.05 using Student’s _T_-test) for the following change scores: &, high – placebo; %, low – placebo; #, high – low. Error bars represent standard error of the mean. Bar groupings indicate, from left to right, RSA power calculated from EKGs taken: before capsule administration, 120 minutes after capsule administration, after simulated social acceptance, and after simulated social rejection.
Similar articles
- Acute effects of MDMA on autonomic cardiac activity and their relation to subjective prosocial and stimulant effects.
Clark CM, Frye CG, Wardle MC, Norman GJ, de Wit H. Clark CM, et al. Psychophysiology. 2015 Mar;52(3):429-35. doi: 10.1111/psyp.12327. Epub 2014 Sep 11. Psychophysiology. 2015. PMID: 25208727 Free PMC article. - MDMA alters emotional processing and facilitates positive social interaction.
Wardle MC, de Wit H. Wardle MC, et al. Psychopharmacology (Berl). 2014 Oct;231(21):4219-29. doi: 10.1007/s00213-014-3570-x. Epub 2014 Apr 12. Psychopharmacology (Berl). 2014. PMID: 24728603 Free PMC article. - Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others.
Bedi G, Hyman D, de Wit H. Bedi G, et al. Biol Psychiatry. 2010 Dec 15;68(12):1134-40. doi: 10.1016/j.biopsych.2010.08.003. Epub 2010 Oct 14. Biol Psychiatry. 2010. PMID: 20947066 Free PMC article. Clinical Trial. - The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.
Kamilar-Britt P, Bedi G. Kamilar-Britt P, et al. Neurosci Biobehav Rev. 2015 Oct;57:433-46. doi: 10.1016/j.neubiorev.2015.08.016. Epub 2015 Sep 25. Neurosci Biobehav Rev. 2015. PMID: 26408071 Free PMC article. Review. - MDMA-Assisted Therapy as a Means to Alter Affective, Cognitive, Behavioral, and Neurological Systems Underlying Social Dysfunction in Social Anxiety Disorder.
Luoma J, Lear MK. Luoma J, et al. Front Psychiatry. 2021 Sep 27;12:733893. doi: 10.3389/fpsyt.2021.733893. eCollection 2021. Front Psychiatry. 2021. PMID: 34646176 Free PMC article. Review.
Cited by
- From antidepressants and psychotherapy to oxytocin, vagus nerve stimulation, ketamine and psychedelics: how established and novel treatments can improve social functioning in major depression.
Kupferberg A, Hasler G. Kupferberg A, et al. Front Psychiatry. 2024 Oct 14;15:1372650. doi: 10.3389/fpsyt.2024.1372650. eCollection 2024. Front Psychiatry. 2024. PMID: 39469469 Free PMC article. Review. - Design and methodology of the first open-label trial of MDMA-assisted therapy for veterans with post-traumatic stress disorder and alcohol use disorder: Considerations for a randomized controlled trial.
Eaton E, Capone C, Gully BJ, Brown ZE, Monnig M, Worden MS, Swift RM, Haass-Koffler CL. Eaton E, et al. Contemp Clin Trials Commun. 2024 Jul 20;41:101333. doi: 10.1016/j.conctc.2024.101333. eCollection 2024 Oct. Contemp Clin Trials Commun. 2024. PMID: 39262902 Free PMC article. - Systematic review: pain, cognition, and cardioprotection-unpacking oxytocin's contributions in a sport context.
Szabó P, Bonet S, Hetényi R, Hanna D, Kovács Z, Prisztóka G, Križalkovičová Z, Szentpéteri J. Szabó P, et al. Front Physiol. 2024 Jun 10;15:1393497. doi: 10.3389/fphys.2024.1393497. eCollection 2024. Front Physiol. 2024. PMID: 38915776 Free PMC article. - Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy.
Schmid Y, Bershad AK. Schmid Y, et al. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 May;9(5):490-499. doi: 10.1016/j.bpsc.2024.02.001. Epub 2024 Feb 9. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024. PMID: 38341085 Free PMC article. Review. - The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.
Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R. Zaretsky TG, et al. Curr Neuropharmacol. 2024;22(4):636-735. doi: 10.2174/1570159X22666231027111147. Curr Neuropharmacol. 2024. PMID: 38284341 Free PMC article. Review.
References
- Alvares GA, Hickie IB, Guastella AJ. Acute effects of intranasal oxytocin on subjective and behavioral responses to social rejection. Experimental and Clinical Psychopharmacology. 2010;18:316–21. - PubMed
- Bartz JA, Zaki J, Bolger N, Ochsner KN. Social effects of oxytocin in humans: context and person matter. Trends in Cognitive Sciences. 2011;15:301–9. - PubMed
- Baylen CA, Rosenberg H. A review of the acute subjective effects of MDMA/ecstasy. Addiction. 2006;101:933–47. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials